PMC:3342329 / 5919-6044 JSONTXT

Annnotations TAB JSON ListView MergeView

    test3

    {"project":"test3","denotations":[{"id":"T1366","span":{"begin":80,"end":84},"obj":"Protein"},{"id":"T1309","span":{"begin":80,"end":84},"obj":"Protein"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    testone

    {"project":"testone","denotations":[{"id":"T1235","span":{"begin":80,"end":84},"obj":"Protein"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    BioNLP16_Messiy

    {"project":"BioNLP16_Messiy","denotations":[{"id":"T2928","span":{"begin":80,"end":84},"obj":"Protein"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    BioNLP16_DUT

    {"project":"BioNLP16_DUT","denotations":[{"id":"T4190","span":{"begin":80,"end":84},"obj":"Protein"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    2_test

    {"project":"2_test","denotations":[{"id":"22567084-19073147-91707031","span":{"begin":8,"end":10},"obj":"19073147"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    pmc-enju-pas

    {"project":"pmc-enju-pas","denotations":[{"id":"T2520","span":{"begin":113,"end":118},"obj":"NN"},{"id":"T2519","span":{"begin":100,"end":111},"obj":"NN"},{"id":"T2518","span":{"begin":94,"end":99},"obj":"NN"},{"id":"T2517","span":{"begin":85,"end":93},"obj":"VB"},{"id":"T2516","span":{"begin":80,"end":84},"obj":"NN"},{"id":"T2515","span":{"begin":77,"end":79},"obj":"IN"},{"id":"T2514","span":{"begin":68,"end":76},"obj":"VB"},{"id":"T2513","span":{"begin":65,"end":67},"obj":"VB"},{"id":"T2512","span":{"begin":59,"end":64},"obj":"MD"},{"id":"T2511","span":{"begin":53,"end":58},"obj":"NN"},{"id":"T2510","span":{"begin":50,"end":52},"obj":"IN"},{"id":"T2509","span":{"begin":39,"end":49},"obj":"NN"},{"id":"T2508","span":{"begin":34,"end":38},"obj":"IN"},{"id":"T2507","span":{"begin":25,"end":33},"obj":"JJ"},{"id":"T2506","span":{"begin":22,"end":24},"obj":"VB"},{"id":"T2505","span":{"begin":19,"end":21},"obj":"PRP"},{"id":"T2504","span":{"begin":17,"end":18},"obj":"-COMMA-"},{"id":"T2503","span":{"begin":13,"end":17},"obj":"RB"},{"id":"T2502","span":{"begin":10,"end":11},"obj":"-RRB-"},{"id":"T2501","span":{"begin":8,"end":10},"obj":"CD"},{"id":"T2500","span":{"begin":7,"end":8},"obj":"-LRB-"}],"relations":[{"id":"R1544","pred":"arg2Of","subj":"T2519","obj":"T2515"},{"id":"R1545","pred":"arg1Of","subj":"T2519","obj":"T2516"},{"id":"R1546","pred":"arg2Of","subj":"T2519","obj":"T2517"},{"id":"R1547","pred":"arg1Of","subj":"T2519","obj":"T2518"},{"id":"R1742","pred":"arg2Of","subj":"T2501","obj":"T2500"},{"id":"R1749","pred":"arg3Of","subj":"T2502","obj":"T2500"},{"id":"R1755","pred":"arg1Of","subj":"T2506","obj":"T2503"},{"id":"R1768","pred":"arg1Of","subj":"T2506","obj":"T2504"},{"id":"R1769","pred":"arg2Of","subj":"T2507","obj":"T2506"},{"id":"R1774","pred":"arg1Of","subj":"T2509","obj":"T2510"},{"id":"R1779","pred":"arg1Of","subj":"T2509","obj":"T2512"},{"id":"R1780","pred":"arg1Of","subj":"T2509","obj":"T2513"},{"id":"R1783","pred":"arg2Of","subj":"T2509","obj":"T2514"},{"id":"R1784","pred":"arg2Of","subj":"T2511","obj":"T2510"},{"id":"R1792","pred":"arg1Of","subj":"T2514","obj":"T2505"},{"id":"R1799","pred":"arg1Of","subj":"T2514","obj":"T2506"},{"id":"R1801","pred":"arg1Of","subj":"T2514","obj":"T2507"},{"id":"R1802","pred":"arg1Of","subj":"T2514","obj":"T2508"},{"id":"R1803","pred":"arg2Of","subj":"T2514","obj":"T2512"},{"id":"R1804","pred":"arg2Of","subj":"T2514","obj":"T2513"},{"id":"R1805","pred":"arg1Of","subj":"T2514","obj":"T2515"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    bionlp-st-ge-2016-test-proteins

    {"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T1550","span":{"begin":80,"end":84},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T2730","span":{"begin":80,"end":84},"obj":"http://www.uniprot.org/uniprot/P51681"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T1592","span":{"begin":100,"end":111},"obj":"http://purl.obolibrary.org/obo/GO_0032502"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    sentences

    {"project":"sentences","denotations":[{"id":"T1432","span":{"begin":13,"end":112},"obj":"Sentence"},{"id":"T41","span":{"begin":13,"end":112},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    simple1

    {"project":"simple1","denotations":[{"id":"T1704","span":{"begin":80,"end":84},"obj":"Protein"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    DLUT931

    {"project":"DLUT931","denotations":[{"id":"T2788","span":{"begin":80,"end":84},"obj":"Protein"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    bionlp-st-ge-2016-test-ihmc

    {"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T4361","span":{"begin":39,"end":58},"obj":"Negative_regulation"},{"id":"T4346","span":{"begin":77,"end":111},"obj":"Regulation"},{"id":"T4330","span":{"begin":77,"end":111},"obj":"Protein"},{"id":"T4300","span":{"begin":50,"end":58},"obj":"Protein"},{"id":"T4247","span":{"begin":113,"end":118},"obj":"Protein"}],"relations":[{"id":"R3058","pred":"themeOf","subj":"T4300","obj":"T4361"},{"id":"R3062","pred":"themeOf","subj":"T4330","obj":"T4346"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    bionlp-st-ge-2016-spacy-parsed

    {"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T3945","span":{"begin":113,"end":118},"obj":"JJ"},{"id":"T3944","span":{"begin":111,"end":112},"obj":"."},{"id":"T3943","span":{"begin":100,"end":111},"obj":"NN"},{"id":"T3942","span":{"begin":94,"end":99},"obj":"NN"},{"id":"T3941","span":{"begin":85,"end":93},"obj":"VBD"},{"id":"T3940","span":{"begin":80,"end":84},"obj":"NNP"},{"id":"T3939","span":{"begin":77,"end":79},"obj":"IN"},{"id":"T3938","span":{"begin":68,"end":76},"obj":"VBN"},{"id":"T3937","span":{"begin":65,"end":67},"obj":"VB"},{"id":"T3936","span":{"begin":59,"end":64},"obj":"MD"},{"id":"T3935","span":{"begin":53,"end":58},"obj":"NN"},{"id":"T3934","span":{"begin":50,"end":52},"obj":"IN"},{"id":"T3933","span":{"begin":39,"end":49},"obj":"NN"},{"id":"T3932","span":{"begin":34,"end":38},"obj":"IN"},{"id":"T3931","span":{"begin":25,"end":33},"obj":"JJ"},{"id":"T3930","span":{"begin":22,"end":24},"obj":"VBZ"},{"id":"T3929","span":{"begin":19,"end":21},"obj":"PRP"},{"id":"T3928","span":{"begin":17,"end":18},"obj":","},{"id":"T3927","span":{"begin":13,"end":17},"obj":"RB"},{"id":"T3926","span":{"begin":11,"end":12},"obj":"."},{"id":"T3925","span":{"begin":10,"end":11},"obj":"NNP"},{"id":"T3924","span":{"begin":8,"end":10},"obj":"CD"},{"id":"T3923","span":{"begin":7,"end":8},"obj":"NNP"}],"relations":[{"id":"R2774","pred":"nummod","subj":"T3924","obj":"T3925"},{"id":"R2775","pred":"appos","subj":"T3925","obj":"T3923"},{"id":"R2778","pred":"advmod","subj":"T3927","obj":"T3930"},{"id":"R2780","pred":"punct","subj":"T3928","obj":"T3930"},{"id":"R2781","pred":"nsubj","subj":"T3929","obj":"T3930"},{"id":"R2782","pred":"ROOT","subj":"T3930","obj":"T3930"},{"id":"R2783","pred":"acomp","subj":"T3931","obj":"T3930"},{"id":"R2785","pred":"mark","subj":"T3932","obj":"T3938"},{"id":"R2786","pred":"nsubjpass","subj":"T3933","obj":"T3938"},{"id":"R2787","pred":"prep","subj":"T3934","obj":"T3933"},{"id":"R2789","pred":"pobj","subj":"T3935","obj":"T3934"},{"id":"R2790","pred":"aux","subj":"T3936","obj":"T3938"},{"id":"R2791","pred":"auxpass","subj":"T3937","obj":"T3938"},{"id":"R2793","pred":"ccomp","subj":"T3938","obj":"T3930"},{"id":"R2794","pred":"prep","subj":"T3939","obj":"T3938"},{"id":"R2795","pred":"pobj","subj":"T3940","obj":"T3939"},{"id":"R2797","pred":"advcl","subj":"T3941","obj":"T3930"},{"id":"R2798","pred":"compound","subj":"T3942","obj":"T3943"},{"id":"R2799","pred":"dobj","subj":"T3943","obj":"T3941"},{"id":"R2801","pred":"punct","subj":"T3944","obj":"T3930"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}

    bionlp-st-ge-2016-test-tees

    {"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T3024","span":{"begin":39,"end":49},"obj":"Negative_regulation"},{"id":"T3023","span":{"begin":80,"end":84},"obj":"Protein"},{"id":"T3022","span":{"begin":53,"end":58},"obj":"Protein"}],"relations":[{"id":"R1938","pred":"themeOf","subj":"T3022","obj":"T3024"}],"text":"stasis [33]. Thus, it is possible that inhibition of NF-κB could be involved in CCR5 mediated tumor development.\nNF-κB transc"}